How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not filed but data is shared. Yet they are still able to make money.

11 Open Source Drug Discovery with M4K Pharma's Owen Roberts

In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.

Business

Share 11 Open Source Drug Discovery with M4K Pharma's Owen Roberts

Sign up to save your podcasts

11 Open Source Drug Discovery with M4K Pharma's Owen Roberts

11 Open Source Drug Discovery with M4K Pharma's Owen Roberts

More shows like Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech

Freakonomics Radio

Responsive Lab Podcast

The New Abnormal

Hard Fork

Fast Politics with Molly Jong-Fast